Mankind Pharma

Mankind Pharma Dividend

The Dividend of Mankind Pharma (MANKIND.NS) as of Nov 21, 2026 is 1.00 INR.

Dividend

1.00INR

Dividend yield

0.04 %

Last updated:

How much dividend does Mankind Pharma 2026 pay?

According to the latest status from November 2026, Mankind Pharma paid a total of 1.00 INR per share in dividends within the last 12 months. With the current Mankind Pharma price of 2,665.00 INR, this corresponds to a dividend yield of 0.04 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 0.04%. The payout ratio is around 2% of earnings.

Historical Mankind Pharma Dividends

A dividend is paid times per year. Last year, the payout months were and September.

Historical Mankind Pharma Dividends
PaydateDividend
1.00INR

The Mankind Pharma Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
1.00 INR
Jan 1, 2026
1.00 INR
Jan 1, 2027 (e)
4.00 INR
Jan 1, 2028 (e)
4.00 INR
Jan 1, 2029 (e)
4.00 INR
Jan 1, 2030 (e)
4.00 INR
The Mankind Pharma Dividend history
YEARDividendYoY
est4.00INR0.00%
est4.00INR0.00%
est4.00INR0.00%
est4.00INR+300.00%
1.00INR0.00%
1.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Mankind Pharma dividend history and estimates

In 2025, Mankind Pharma paid a dividend amounting to 1.00 INR. Dividend means that Mankind Pharma distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2025 (e)
0.00 INR
1.00 INR
Jan 1, 2026 (e)
1.00 INR
3.00 INR
Jan 1, 2027 (e)
0.00 INR
4.00 INR
Jan 1, 2028 (e)
0.00 INR
4.00 INR
Jan 1, 2029 (e)
0.00 INR
4.00 INR

Is the Mankind Pharma Dividend Safe?

Mankind Pharma has been increasing the dividend for 0 years.

Analysts expect a Dividend Increase of 100.00% for the current fiscal year.

Mankind Pharma dividend payout ratio

In 2025, Mankind Pharma had a payout ratio of 2.08%. The payout ratio indicates the percentage of the company's profits that Mankind Pharma distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
2.08 %
Jan 1, 2023
2.08 %
Jan 1, 2024
2.08 %
Jan 1, 2025
2.08 %
Jan 1, 2026
2.08 %
Jan 1, 2027 (e)
6.77 %
Jan 1, 2028 (e)
5.53 %
Jan 1, 2029 (e)
4.56 %

Dividend Details

Understanding Mankind Pharma's Dividend Distributions

Mankind Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Mankind Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Mankind Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Mankind Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Mankind Pharma Stock analysis

What does Mankind Pharma do? Mankind Pharma Ltd develops, manufactures, and markets pharmaceutical formulations across therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, and respiratory treatments. The company's portfolio includes brands such as Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, and Monticop, targeting acute and chronic conditions. These products are sold to healthcare providers, hospitals, and pharmacies across India, serving patients in diverse medical needs. The firm generates revenue through the sale of prescription and over-the-counter pharmaceuticals, leveraging its extensive portfolio in multiple therapeutic segments. Mankind Pharma focuses on therapeutic areas like anti-diabetic, dermatology, gynecology, pain/analgesics, urology, ophthalmology, and antiviral treatments, with brands such as Glimestar for diabetes and Manforce (Rx) for sexual health. The company's consumer healthcare products complement its prescription offerings, expanding market reach. Revenue streams come from the direct sale of branded formulations to distributors and retail chains, with no mention of external partnerships or additional services beyond pharmaceutical manufacturing and marketing. The company's therapeutic portfolio spans anti-malarial, blood-related, hormones, antineoplastic, hepatoprotective, and parenteral treatments, supported by brands like Cefakind for infections and Zenflox for respiratory issues. Sales are driven by its diverse product range covering both prescription and consumer healthcare segments, with no indication of licensing agreements or third-party collaborations. Mankind Pharma's revenue model relies solely on the marketing and distribution of its own branded pharmaceutical products within India's healthcare ecosystem. Mankind Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mankind Pharma stock

Over the past 12 months, Mankind Pharma paid a dividend of 1.00 INR . This corresponds to a dividend yield of about 0.04 %. For the coming 12 months, Mankind Pharma is expected to pay a dividend of 4.00 INR.

The current dividend yield of Mankind Pharma is 0.04 %.

Mankind Pharma paid dividends every year for the past 1 years.

For the upcoming 12 months, dividends amounting to 4.00 INR are expected. This corresponds to a dividend yield of 0.15 %.

Mankind Pharma is assigned to the 'Health' sector.

To receive the latest dividend of Mankind Pharma from 8/30/2025 amounting to 1 INR, you needed to have the stock in your portfolio before the ex-date on 8/8/2025.

The last dividend was paid out on 8/30/2025.

In the year 2025, Mankind Pharma distributed 1 INR as dividends.

The dividends of Mankind Pharma are distributed in INR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Mankind Pharma